155 results
8-K
EX-10.1
CRVO
CervoMed Inc
20 May 24
CervoMed to Appoint William Elder as Chief Financial Officer
4:07pm
of Employment, the Executive agrees to cooperate with the Company Group in any internal investigation, any administrative, regulatory, or judicial proceeding
8-K
EX-10.2
CRVO
CervoMed Inc
20 May 24
CervoMed to Appoint William Elder as Chief Financial Officer
4:07pm
to, or testifying or otherwise assisting any investigation or proceeding brought by any federal or state regulatory or law enforcement agency or legislative
8-K
EX-10.1
pj9inhtxu foghgvws
28 Mar 24
CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
8:36am
8-K
EX-4.2
lvrslm7gm9f9gtdbn
28 Mar 24
CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
8:36am
8-K
EX-10.3
xsbssw60qll9a31
2 Feb 24
Entry into a Material Definitive Agreement
4:17pm
8-K
EX-10.1
gitd5w1
2 Feb 24
Entry into a Material Definitive Agreement
4:17pm
8-K
EX-10.2
km3j2l9576fjaa
2 Feb 24
Entry into a Material Definitive Agreement
4:17pm
8-K
EX-10.1
dlevdkimx567k89m
17 Nov 23
Entry into a Material Definitive Agreement
5:03pm
S-8
6u58p0vvd
29 Sep 23
Registration of securities for employees
4:21pm
8-K/A
EX-99.2
67mp3y8q35t5hqiy
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K/A
EX-99.3
4hw57ap
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K
EX-10.9
9do0mm
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
424B3
1q87zrzps1yp
13 Jul 23
Prospectus supplement
4:32pm
S-4/A
lnw28o0k64b 35
22 Jun 23
Registration of securities issued in business combination transactions (amended)
9:46pm